New tech tracks blood sugar to protect transplanted kidneys
NCT ID NCT07271433
Summary
This study tested if using a continuous glucose monitor (CGM) could help manage blood sugar in people with type 2 diabetes after they received a kidney transplant. Twenty patients wore the monitor for three months to see if better glucose control could reduce hospital readmissions and problems with the new kidney. The goal was to see if this technology could be a useful tool for protecting the health of the transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.